Drug interactions in clinical medicine.

[1]  G. Boman,et al.  Drug interaction: decreased serum concentrations of rifampicin when given with P.A.S. , 1971, Lancet.

[2]  M. Kendall,et al.  Xylose Test: Effect of Aspirin and Indomethacin , 1971, British medical journal.

[3]  E. Vesell,et al.  Impairment of drug metabolism in man by allopurinol and nortriptyline. , 1970, The New England journal of medicine.

[4]  R. Mcdonald,et al.  Antagonism of hypotensive action of bethanidine by "common cold" remedy. , 1970, British medical journal.

[5]  E. Sellers,et al.  Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. , 1970, The New England journal of medicine.

[6]  M. Rowland,et al.  Griseofulvin-phenobarbital interaction in man. , 1970, JAMA.

[7]  L. Bernstein,et al.  The absorption and malabsorption of folic acid and its polyglutamates. , 1970, The American journal of medicine.

[8]  Necheles Tf,et al.  Malabsorption of folate polyglutamates associated with oral contraceptive therapy. , 1970 .

[9]  C. Baugh,et al.  Effects of phenytoin on folic-acid conjugases in man. , 1969, Lancet.

[10]  E. Werk,et al.  Interference in the effect of dexamethasone by diphenylhydantoin. , 1969, The New England journal of medicine.

[11]  J. Hollifield,et al.  The influence of cholestyramine on thyroxine absorption. , 1969, JAMA.

[12]  Stowers Jm,et al.  Studies on the mechanism of weight reduction by phenformin. , 1969 .

[13]  A. Conney.  Drug metabolism and therapeutics. , 1969, The New England journal of medicine.

[14]  J. Perel,et al.  Methylphenidate Interaction With Both Anticonvulsants and Ethyl Biscoumacetate , 1969 .

[15]  J. Perel,et al.  Methylphenidate interaction with both anticonvulsants and ethyl biscoumacetate. , 1969, JAMA.

[16]  D. Sylwester,et al.  The effects of phenobarbital, chloral betaine, and glutethimide administration on warfarin plasma levels and hypoprothrombinemic responses in man , 1969, Clinical pharmacology and therapeutics.

[17]  J. Udall.  Drug interference with warfarin therapy , 1969 .

[18]  Streiff Rr.  Malabsorption of polyglutamic folic acid secondary to oral contraceptives. , 1969 .

[19]  M. Kristensen,et al.  Accumulation of chlorpropamide caused by dicoumarol. , 2009, Acta medica Scandinavica.

[20]  I. Chanarin,et al.  Absorption and Utilization of Polyglutamyl Forms of Folate in Man , 1968, British medical journal.

[21]  K. Melmon,et al.  The clinician's approach to drug interactions. , 1968, California medicine.

[22]  R. Bressler,et al.  Biochemical Basis of the Sulfonylurea-induced Antabuse Syndrome , 1968, Diabetes.

[23]  T. Necheles,et al.  Mechanism of folate deficiency in patients receiving phenytoin. , 1968, Lancet.

[24]  A. Anton.  The effect of disease, drugs, and dilution on the binding of sulfonamides in human plasma , 1968, Clinical pharmacology and therapeutics.

[25]  I. Rosenberg,et al.  Impairment of intestinal deconjugation of dietary folate. A possible explanation of megaloblastic anaemia associated with phenytoin therapy. , 1968, Lancet.

[26]  S. Consolo.  An interaction between desipramine and phenylbutazone , 1968, The Journal of pharmacy and pharmacology.

[27]  J. Oates,et al.  Inhibition of monoamine oxidase in man by furazolidone , 1968, Clinical pharmacology and therapeutics.

[28]  J. Toole,et al.  Neural effects of nitrofurantoin. , 1968, Archives of neurology.

[29]  L. A. Healey,et al.  The renal excretion of indomethacin and its inhibition by probenecid , 1968, Clinical pharmacology and therapeutics.

[30]  D. Williams,et al.  The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids. , 1968, Biochemical pharmacology.

[31]  J. Oates,et al.  Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. , 1967, JAMA.

[32]  H. M. Solomon,et al.  Change in receptor site affinity: A proposed explanation for the potentiating effect of D‐thyroxine on the anticoagulant response to warfarin , 1967, Clinical pharmacology and therapeutics.

[33]  H. M. Solomon,et al.  Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjects. , 1967, Metabolism: clinical and experimental.

[34]  J. B. Field,et al.  Potentiation of acetohexamide hypoglycemia by phenylbutazone. , 1967, The New England journal of medicine.

[35]  A. Conney.  Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[36]  M. Dahlke,et al.  Malabsorption of folic acid due to diphenylhydantoin. , 1967, Blood.

[37]  H. M. Solomon,et al.  The effect of phenyramidol on the metabolism of diphenylhydantoin , 1967, Clinical pharmacology and therapeutics.

[38]  H M Solomon,et al.  The effect of various drugs on the binding of warfarin-14C to human albumin. , 1967, Biochemical pharmacology.

[39]  O. Olesen.  The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine. , 1967, Archives of neurology.

[40]  G. Levy,et al.  Effect of certain nonsteroid antirheumatic drugs on active amino acid transport across the small intestine. , 1967, Journal of pharmaceutical sciences.

[41]  P M Aggeler,et al.  Potentiation of anticoagulant effect of warfarin by phenylbutazone. , 1967, The New England journal of medicine.

[42]  H. M. Solomon,et al.  II. The effect of D‐thyroxine, clofibrate, and norethandrolone , 1967 .

[43]  H. Frey,et al.  Interaction of amphetamine with anticonvulsant drugs. II. Effect of amphetamine on the absorption of anticonvulsant drugs. , 2009, Acta pharmacologica et toxicologica.

[44]  O. Olesen.  Disulfiramum (antabuse) as inhibitor of phenytoin metabolism. , 2009, Acta pharmacologica et toxicologica.

[45]  H. M. Solomon,et al.  The effect of phenyramidol on the metabolism of bishydroxycoumarin. , 1966, The Journal of pharmacology and experimental therapeutics.

[46]  M. Weiss,et al.  The effect of chloral hydrate on bishydroxycoumarin metabolism; a fatal outcome. , 1966, JAMA.

[47]  M. Kristensen,et al.  Dicoumarol-induced diphenylhydantoin intoxication. , 1966, Lancet.

[48]  S. D. Gokhale,et al.  Antagonism of adrenergic neuron blockade in hypertensive subjects , 1966, Clinical pharmacology and therapeutics.

[49]  D. L. Sorby,et al.  Effects of Adsorbents on Drug Absorption II: Effect of an Antidiarrhea Mixture on Promazine Absorption , 1966 .

[50]  C. Kunin.  Clinical pharmacology of the new penicillins: II. Effect of drugs which interfere with binding to serum proteins , 1966, Clinical pharmacology and therapeutics.

[51]  S. Wagner,et al.  SUPPRESSION OF SALICYLATE‐INDUCED URICOSURIA BY PHENYLBUTAZONE , 1966, The American journal of the medical sciences.

[52]  B. Brodie.  Displacement of One Drug by Another from Carrier or Receptor Sites , 1965, Proceedings of the Royal Society of Medicine.

[53]  M. Milne.  Influence of Acid-Base Balance on Efficacy and Toxicity of Drugs , 1965, Proceedings of the Royal Society of Medicine.

[54]  F. Sjöqvist,et al.  Psychotropic Drugs (2) Interaction between Monoamine Oxidase (MAO) Inhibitors and other Substances , 1965, Proceedings of the Royal Society of Medicine.

[55]  A. L. Sheffner,et al.  The Interaction Between Cholestyramine and Drugs , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[56]  L. Isaac,et al.  Interaction of antihistaminics with norepinephrine uptake: a cocaine-like effect. , 1965, Life sciences.

[57]  A. Miller,et al.  Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case). , 1965, Postgraduate medical journal.

[58]  A. Conney,et al.  Drug interactions in man , 1965, Clinical pharmacology and therapeutics.

[59]  A. Beckett,et al.  INFLUENCE OF URINARY PH ON EXCRETION OF AMPHETAMINE. , 1965, Lancet.

[60]  C. Kunin.  Enhancement of Antimicrobial Activity of Penicillins and Other Antibiotics in Human Serum by Competitive Serum Binding Inhibitors.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[61]  J. Burns.  IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY. , 1964, The American journal of medicine.

[62]  J. MacGee,et al.  EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN. , 1964, The Journal of clinical investigation.

[63]  B. Brodie,et al.  RESERPINE-INDUCED RELEASE OF DRUGS FROM SYMPATHETIC NERVE ENDINGS. , 1964, Life sciences.

[64]  M. J. Eisen.  COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE. , 1964, JAMA.

[65]  S. L. Fox.  POTENTIATION OF ANTICOAGULANTS CAUSED BY PYRAZOLE COMPOUNDS. , 1964, JAMA.

[66]  I. M. Vigran.  DANGEROUS POTENTIATION OF MEPERIDINE HYDROCHLORIDE BY PARGYLINE HYDROCHLORIDE. , 1964, JAMA.

[67]  M. Kristensen,et al.  SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS. , 1963, Lancet.

[68]  L. Goldman,et al.  THE ABSORPTION CHARACTERISTICS OF PARACETAMOL TABLETS IN MAN , 1963, The Journal of pharmacy and pharmacology.

[69]  A. Anton.  A drug-induced change in the distribution and renal excretion of sulfonamides. , 1961, The Journal of pharmacology and experimental therapeutics.

[70]  M. Finland,et al.  Clinical pharmacology of the tetracycline antibiotics , 1961, Clinical pharmacology and therapeutics.

[71]  A. Anton.  The relation between the binding of sulfonamides to albumin and their antibacterial efficacy. , 1960, The Journal of pharmacology and experimental therapeutics.

[72]  E. D. Jacobson,et al.  An experimental malabsorption syndrome induced by neomycin. , 1960, The American journal of medicine.

[73]  M. J. Smith,et al.  Effects of salicylate on the metabolic activity of the small intestine of the rat. , 1958, The American journal of physiology.

[74]  G. Rowe,et al.  Observations on the pharmacology of mecamylamine. , 1957, Clinical science.

[75]  B. Brodie,et al.  The gastric secretion of drugs: a pH partition hypothesis. , 1957, The Journal of pharmacology and experimental therapeutics.

[76]  C. Zubrod,et al.  STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VIII. THE PHYSIOLOGICAL DISPOSITION OF PAMAQUINE. , 1948, The Journal of clinical investigation.

[77]  Learmonth.  Surgery in portal hypertension. , 1947, Lancet.